Overview

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Status:
Terminated
Trial end date:
2016-11-07
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well green tea extract works in treating patients with low-risk prostate cancer. Green tea extract contains ingredients that may prevent or slow the growth of certain cancers.
Phase:
Phase 2
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Sanjay Gupta PhD
Collaborator:
National Cancer Institute (NCI)